Viraferonpeg and hepatic cirrhosis Patient Reports February 11, 2012



Viraferonpeg Side Effects Report #4892022-1
Viraferonpeg side effect was reported by a Health Professional from UNITED KINGDOM on Jan 12, 2006. Male patient, 66 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatic cirrhosis, hepatic failure, hypotension, hypothermia What is  hypothermia, pancreatitis chronic, shock, spleen disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, OMEPRAZOLE, SPIRONOLACTONE, FRUSEMIDE, THIAMINE, PAROXETINE, METHADONE, SALBUTAMOL SULPHATE. Patient was hospitalized. Patient died on 03/04/2005.

Viraferonpeg Side Effects Report #6140296-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Mar 25, 2009. Male patient, 64 years of age, weighting 178.6 lb, was diagnosed with hepatitis c What is  hepatitis c, insomnia and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: agitation, disease progression, gastrointestinal haemorrhage, hepatic cirrhosis, hepatic encephalopathy, hyponatraemia, insomnia, portal hypertension, respiratory disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with XANAX. Patient was hospitalized. Patient died.

Viraferonpeg Side Effects Report #5729626-X
Viraferonpeg side effect was reported by a Health Professional from UNITED KINGDOM on Apr 22, 2008. Male patient, 58 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatic cirrhosis, liver disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.

Viraferonpeg Side Effects Report #5768636-3
Viraferonpeg side effect was reported by a Health Professional from UNITED KINGDOM on June 03, 2008. Male patient, 58 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatic cirrhosis, hepatic failure. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #5710663-6
Viraferonpeg side effect was reported by a Physician from FRANCE on Apr 10, 2008. Male patient, 53 years of age, weighting 273.4 lb, was diagnosed with hepatitis c What is  hepatitis c, phlebitis and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: anaemia, haematoma, hepatic cirrhosis, overdose, staphylococcal sepsis, thrombocytopenia. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, PREVISCAN, NEUPOGEN, TEMESTA, ZOLOFT, AVLOCARDYL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5755222-4
Viraferonpeg side effect was reported by a Physician from FRANCE on May 23, 2008. Male patient, 53 years of age, weighting 273.4 lb, was diagnosed with hepatitis c What is  hepatitis c, phlebitis and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: anaemia, dysphonia, haematoma, hepatic cirrhosis, international normalised ratio increased, overdose, phlebitis, spondylolisthesis, staphylococcal sepsis. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, PREVISCAN, NEUPOGEN, LORAZEPAM, ZOLOFT, AVLOCARDYL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4869096-7
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 21, 2005. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: condition aggravated, cytolytic hepatitis, hepatic cirrhosis, lobar pneumonia, pancreatitis, renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with DAPSONE, SUSTIVA, COMBIVIR, ZEFFIX, ALDACTONE. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4995827-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Apr 24, 2006. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, hepatic cirrhosis, hyperbilirubinaemia, lipase increased, lobar pneumonia, pancreatitis, renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with DAPSONE, SUSTIVA, COMBIVIR, LAMIVUDINE, ZELITREX, ALDACTONE. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4758191-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 22, 2005. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with hepatitis c What is  hepatitis c, hiv infection What is  hiv infection, epilepsy What is  epilepsy and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: haemolytic anaemia, hepatic cirrhosis, nervous system disorder, pyrexia, refractoriness to platelet transfusion, thrombotic thrombocytopenic purpura. Viraferonpeg dosage: unknown. During the same period patient was treated with COPEGUS, ZIAGEN, VIREAD, SUSTIVA, NEURONTIN, IMODIUM. Patient was hospitalized. Patient died on 05/07/2005.


Viraferonpeg Side Effects Report #5259583-4
Viraferonpeg side effect was reported by a Health Professional from UNITED KINGDOM on Feb 20, 2007. Female patient, 50 years of age, was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatic cirrhosis, hepatic neoplasm malignant. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Viraferonpeg